Evidence map›Paper›PMID 28046129›Full record

ArticlePloS one2017

Isolation, Culture and Characterization of Hirsutella sinensis Mycelium from Caterpillar Fungus Fruiting Body.

Yun-Fei Ko, Jian-Ching Liau, Chien-Sheng Lee, Chen-Yaw Chiu, Jan Martel, Chuan-Sheng Lin, Shun-Fu Tseng, David M Ojcius, Chia-Chen Lu, Hsin-Chih Lai and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Enhanced production of cordycepin inBiotechnology reports (Amsterdam, Netherlands) · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Yun-Fei KoChang Gung Biotechnology Corporation, Taipei, Taiwan, Republic of China.
Jian-Ching LiauChang Gung Biotechnology Corporation, Taipei, Taiwan, Republic of China.
Chien-Sheng LeeChang Gung Biotechnology Corporation, Taipei, Taiwan, Republic of China.
Chen-Yaw ChiuBiochemical Engineering Research Center, Ming Chi University of Technology, New Taipei City, Taiwan, Republic of China.
Jan MartelChang Gung Immunology Consortium, Linkou Chang Gung Memorial Hospital, New Taipei City, Taiwan, Republic of China, and Chang Gung University, Gueishan, Taoyuan, Taiwan, Republic of China.
Chuan-Sheng LinChang Gung Immunology Consortium, Linkou Chang Gung Memorial Hospital, New Taipei City, Taiwan, Republic of China, and Chang Gung University, Gueishan, Taoyuan, Taiwan, Republic of China.
Shun-Fu TsengChang Gung Immunology Consortium, Linkou Chang Gung Memorial Hospital, New Taipei City, Taiwan, Republic of China, and Chang Gung University, Gueishan, Taoyuan, Taiwan, Republic of China.
David M OjciusChang Gung Immunology Consortium, Linkou Chang Gung Memorial Hospital, New Taipei City, Taiwan, Republic of China, and Chang Gung University, Gueishan, Taoyuan, Taiwan, Republic of China.
Chia-Chen LuChang Gung Immunology Consortium, Linkou Chang Gung Memorial Hospital, New Taipei City, Taiwan, Republic of China, and Chang Gung University, Gueishan, Taoyuan, Taiwan, Republic of China.
Hsin-Chih LaiChang Gung Immunology Consortium, Linkou Chang Gung Memorial Hospital, New Taipei City, Taiwan, Republic of China, and Chang Gung University, Gueishan, Taoyuan, Taiwan, Republic of China.
John D YoungChang Gung Biotechnology Corporation, Taipei, Taiwan, Republic of China.
Linkou Chang Gung Memorial Hospital · TWChang Gung University · TWChang Gung Memorial Hospital · TWChang Gung University of Science and Technology · TWGolden Biotech (Taiwan) · TWMing Chi University of Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The caterpillar fungus Ophiocordyceps sinensis (previously called Cordyceps sinensis) has been used for centuries in Asia as a tonic to improve health and longevity. Recent studies show that O. sinensis produces a wide range of biological effects on cells, laboratory animals and humans, including anti-fatigue, anti-infection, anti-inflammatory, antioxidant, and anti-tumor activities. In view of the rarity of O. sinensis fruiting bodies in nature, cultivation of its anamorph mycelium represents a useful alternative for large-scale production. However, O. sinensis fruiting bodies harvested in nature harbor several fungal contaminants, a phenomenon that led to the isolation and characterization of a large number of incorrect mycelium strains. We report here the isolation of a mycelium from a fruiting body of O. sinensis and we identify the isolate as O. sinensis' anamorph (also called Hirsutella sinensis) based on multi-locus sequence typing of several fungal genes (ITS, nrSSU, nrLSU, RPB1, RPB2, MCM7, β-tubulin, TEF-1α, and ATP6). The main characteristics of the isolated mycelium, including its optimal growth at low temperature (16°C) and its biochemical composition, are similar to that of O. sinensis fruiting bodies, indicating that the mycelium strain characterized here may be used as a substitute for the rare and expensive O. sinensis fruiting bodies found in nature.

Indexed as

PhylogenyChromatography, High Pressure LiquidCordycepsDNA, FungalDNA, Ribosomal SpacerFruiting Bodies, FungalMultilocus Sequence TypingMyceliumMycological Typing TechniquesDNA, FungalDNA, Ribosomal Spacer

Identifiers

PMID28046129
PMCPMC5207747
OpenAlexW2569046992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.